Business NewsPR NewsWire • ViroPharma Launches 'Ryze Above(TM)', A Personalized Patient Resources Program For Patients With Hereditary Angioedema (HAE)

ViroPharma Launches 'Ryze Above(TM)', A Personalized Patient Resources Program For Patients With Hereditary Angioedema (HAE)

ViroPharma Launches 'Ryze Above(TM)', A Personalized Patient Resources Program For Patients With Hereditary Angioedema (HAE)

EXTON, Pa., March 19 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®.  The Ryze Above program was created

View More : http://www.prnewswire.com/news-releases/viropharma-launches-ryze-abovetm-a-personalized-patient-resources-program-for-pa...
Releted News by prnewswire
Scientific Data Relating to Cinryze(TM) (C1 Esterase Inhibitor [Human]) Presented at First International Congress of the Southern European Allergy Society
ViroPharma Launches 'Ryze Above(TM)', A Personalized Patient Resources Program For Patients With Hereditary Angioedema (HAE)
LearnSomething Adds Senior Sales Reps to Keep Pace with Demand